270 related articles for article (PubMed ID: 34068946)
1. Data-Driven Mathematical Model of Osteosarcoma.
Le T; Su S; Kirshtein A; Shahriyari L
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068946
[TBL] [Abstract][Full Text] [Related]
2. Immune classification of osteosarcoma.
Le T; Su S; Shahriyari L
Math Biosci Eng; 2021 Feb; 18(2):1879-1897. PubMed ID: 33757216
[TBL] [Abstract][Full Text] [Related]
3. Data Driven Mathematical Model of Colon Cancer Progression.
Kirshtein A; Akbarinejad S; Hao W; Le T; Su S; Aronow RA; Shahriyari L
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33291412
[TBL] [Abstract][Full Text] [Related]
4. Investigating Optimal Chemotherapy Options for Osteosarcoma Patients through a Mathematical Model.
Le T; Su S; Shahriyari L
Cells; 2021 Aug; 10(8):. PubMed ID: 34440778
[TBL] [Abstract][Full Text] [Related]
5. A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration.
Mohammad Mirzaei N; Su S; Sofia D; Hegarty M; Abdel-Rahman MH; Asadpoure A; Cebulla CM; Chang YH; Hao W; Jackson PR; Lee AV; Stover DG; Tatarova Z; Zervantonakis IK; Shahriyari L
J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683171
[TBL] [Abstract][Full Text] [Related]
6. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY
Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
8. Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer.
Budithi A; Su S; Kirshtein A; Shahriyari L
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071939
[TBL] [Abstract][Full Text] [Related]
9. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.
Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H
Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076
[TBL] [Abstract][Full Text] [Related]
10. Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.
Ligon JA; Choi W; Cojocaru G; Fu W; Hsiue EH; Oke TF; Siegel N; Fong MH; Ladle B; Pratilas CA; Morris CD; Levin A; Rhee DS; Meyer CF; Tam AJ; Blosser R; Thompson ED; Suru A; McConkey D; Housseau F; Anders R; Pardoll DM; Llosa N
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34021032
[TBL] [Abstract][Full Text] [Related]
11. Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.
Pahl JH; Kwappenberg KM; Varypataki EM; Santos SJ; Kuijjer ML; Mohamed S; Wijnen JT; van Tol MJ; Cleton-Jansen AM; Egeler RM; Jiskoot W; Lankester AC; Schilham MW
J Exp Clin Cancer Res; 2014 Mar; 33(1):27. PubMed ID: 24612598
[TBL] [Abstract][Full Text] [Related]
12. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma.
Cao H; Quan S; Zhang L; Chen Y; Jiao G
Oncol Lett; 2021 May; 21(5):391. PubMed ID: 33777214
[TBL] [Abstract][Full Text] [Related]
13. An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol.
Qomlaqi M; Bahrami F; Ajami M; Hajati J
Math Biosci; 2017 Oct; 292():1-9. PubMed ID: 28713023
[TBL] [Abstract][Full Text] [Related]
14. m6A-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Osteosarcoma.
Bi Y; Meng D; Wan M; Xu N; Xu Y; Yuan K; Liu P; Fang H; Hu H; Lan S
Comput Intell Neurosci; 2022; 2022():9315283. PubMed ID: 35978902
[TBL] [Abstract][Full Text] [Related]
15. Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
Curtis LT; Sebens S; Frieboes HB
Cancer Immunol Immunother; 2021 May; 70(5):1475-1488. PubMed ID: 33180183
[TBL] [Abstract][Full Text] [Related]
16. Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions.
Wolf-Dennen K; Gordon N; Kleinerman ES
Oncoimmunology; 2020; 9(1):1747677. PubMed ID: 32313728
[TBL] [Abstract][Full Text] [Related]
17. CD163(+) M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma.
Han Q; Shi H; Liu F
Int Immunopharmacol; 2016 May; 34():101-106. PubMed ID: 26938675
[TBL] [Abstract][Full Text] [Related]
18. Anti-TGF-β antibody combined with dendritic cells produce antitumor effects in osteosarcoma.
Kawano M; Itonaga I; Iwasaki T; Tsuchiya H; Tsumura H
Clin Orthop Relat Res; 2012 Aug; 470(8):2288-94. PubMed ID: 22415727
[TBL] [Abstract][Full Text] [Related]
19. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
20. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma.
Heymann MF; Lézot F; Heymann D
Cell Immunol; 2019 Sep; 343():103711. PubMed ID: 29117898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
